ROCHE HLDGS AGROCHE HLDGS AGROCHE HLDGS AG

ROCHE HLDGS AG

No trades
See on Supercharts
Next report date
Report period
H1 2024
EPS estimate
9.31CHF
Revenue estimate
‪29.98 B‬CHF
Market capitalization
‪177.05 B‬CHF
‪11.50 B‬CHF
‪58.72 B‬CHF
‪680.49 M‬
Beta (1Y)
1.09

About ROCHE I

CEO
Thomas Schinecker
Headquarters
Basel
Website
Employees (FY)
‪103.61 K‬
Founded
1896
FIGI
BBG0089X2L65
Roche Holding AG is a research healthcare company. It operates through the Pharmaceuticals and Diagnostics segments. The Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RHO5 is 221.240 CHF — it has increased by 0.76% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange ROCHE HLDGS AG stocks are traded under the ticker RHO5.
ROCHE HLDGS AG is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
RHO5 stock is 0.77% volatile and has beta coefficient of 1.09. Check out the list of the most volatile stocks — is ROCHE HLDGS AG there?
RHO5 earnings for the last quarter are 10.10 CHF per share, whereas the estimation was 10.40 CHF resulting in a −2.90% surprise. The estimated earnings for the next quarter are 8.48 CHF per share. See more details about ROCHE HLDGS AG earnings.
ROCHE HLDGS AG revenue for the last quarter amounts to ‪29.78 B‬ CHF despite the estimated figure of ‪30.30 B‬ CHF. In the next quarter revenue is expected to reach ‪29.26 B‬ CHF.
Yes, you can track ROCHE HLDGS AG financials in yearly and quarterly reports right on TradingView.
RHO5 stock has risen by 0.64% compared to the previous week, the month change is a 2.98% fall, over the last year ROCHE HLDGS AG has showed a 20.57% decrease.
RHO5 net income for the last quarter is ‪4.36 B‬ CHF, while the quarter before that showed ‪7.14 B‬ CHF of net income which accounts for −38.90% change. Track more ROCHE HLDGS AG financial stats to get the full picture.
Today ROCHE HLDGS AG has the market capitalization of ‪176.19 B‬, it has increased by 2.05% over the last week.
Yes, RHO5 dividends are paid annually. The last dividend per share was 9.60 CHF. As of today, Dividend Yield (TTM)% is 4.34%. Tracking ROCHE HLDGS AG dividends might help you take more informed decisions.
ROCHE HLDGS AG dividend yield was 3.93% in 2023, and payout ratio reached 66.71%. The year before the numbers were 3.27% and 61.19% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, RHO5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ROCHE HLDGS AG stock right from TradingView charts — choose your broker and connect to your account.
RHO5 reached its all-time high on Apr 11, 2022 with the price of 403.110 CHF, and its all-time low was 217.269 CHF and was reached on Apr 8, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has ‪103.61 K‬ employees. See our rating of the largest employees — is ROCHE HLDGS AG on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ROCHE HLDGS AG technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ROCHE HLDGS AG stock shows the sell signal. See more of ROCHE HLDGS AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ROCHE HLDGS AG future price: according to them, RHO5 price has a max estimate of 428.00 CHF and a min estimate of 210.00 CHF. Read a more detailed ROCHE HLDGS AG forecast: see what analysts think of ROCHE HLDGS AG and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ROCHE HLDGS AG EBITDA is ‪19.82 B‬ CHF, and current EBITDA margin is 33.76%. See more stats in ROCHE HLDGS AG financial statements.